The technical feasibility and potential benefits of voxel-based nonuniform dose prescriptions for biologically heterogeneous tumors have been widely demonstrated. In some cases, an "ideal" dose prescription has been generated by individualizing the dose to every voxel within the target, but often this voxel-based prescription has been discretized into a small number of compartments. The number of dose levels utilized and the methods used for prescribing doses and assigning tumor voxels to different dose compartments have varied significantly. The authors present an investigation into the relationship between the complexity of the dose prescription and the tumor control probability ͑TCP͒ for a number of these methods. The linear quadratic model of cell killing was used in conjunction with a number of modeled tumors heterogeneous in clonogen density, oxygenation, or proliferation. Models based on simple mathematical functions, published biological data, and biological image data were investigated. Target voxels were assigned to dose compartments using ͑i͒ simple rules based on the initial biological distribution, ͑ii͒ iterative methods designed to maximize the achievable TCP, or ͑iii͒ methods based on an ideal dose prescription. The relative performance of the simple rules was found to depend on the form of heterogeneity of the tumor, while the iterative and ideal dose methods performed comparably for all models investigated. In all cases the maximum achievable TCP was approached within the first few ͑typically two to five͒ compartments. Results suggest that irrespective of the pattern of heterogeneity, the optimal dose prescription can be well approximated using only a few dose levels but only if both the compartment boundaries and prescribed dose levels are well chosen.
I. INTRODUCTION
There has been much discussion in recent years on the use of deliberately nonuniform dose distributions in radiotherapy, [1] [2] [3] and both the technical feasibility and potential benefits of "dose painting" have been widely demonstrated. [4] [5] [6] [7] [8] [9] [10] [11] [12] There are a number of possible approaches to the incorporation of radiobiological modeling into the treatment planning process. One such methodology is to use a model predicting tumor response to generate a nonuniform dose prescription to the target. 8 This prescription can then be used in conjunction with dose constraints for normal tissue ͑which can be dose volume based or radiobiological and may take into account functional heterogeneity of organs at risk͒ to generate a clinical treatment plan. A schematic diagram of this methodology is presented in Fig. 1 . An alternative is to use models predicting both tumor response and normal tissue damage to directly optimize a treatment plan using a metric such as the probability of uncomplicated tumor control, known as P + . 4, 13 We have adopted the former methodology to enable us to consider the model predicting tumor response independent of that predicting normal tissue response. In this work we consider only the first stage of this process, the generation of a dose prescription ͑shown within the dashed box in Fig. 1͒ . With information on biological variations within a tumor, obtained using functional imaging, it is possible to individualize the dose prescription to each imaged voxel within the target. 8, 12, 14, 15 However, more commonly the target has been divided into a small number of compartments such that the quasicontinuous optimal dose distribution is quantized into a few discrete dose levels. [5] [6] [7] 9, 16 The aim of this work is to investigate the relationship between the complexity of a treatment prescription, measured by the number of prescribed dose levels, and the quality of the plan, represented by the tumor control probability ͑TCP͒.
For an inhomogeneous tumor, the TCP can be increased with respect to a uniform dose distribution by redistributing dose without increasing the integral dose to the target. In general, under these conditions the TCP is expected to increase as the number of dose levels is increased. For any given target, the precise form of this relationship will depend on the heterogeneity of the tumor, the positioning of the boundaries between different compartments, and the choice of prescribed dose levels. The key practical questions are therefore as follows: ͑i͒ How many dose levels are worthwhile? ͑ii͒ What is the optimal method for assigning voxels to different compartments? ͑iii͒ How should we set the prescribed doses to those compartments? We have addressed these questions by investigating the behavior of a number of model tumors with a variety of forms of biological heterogeneity.
II. METHODS

II.A. Radiobiological modeling
If radiation response is described by the linear quadratic model, the surviving fraction ͑SF͒ of tumor cells following irradiation to dose D in f fractions is given by
͑1͒
where ␣ and ␤ are the linear and quadratic parameters of cell kill, T is the overall treatment time, and ␥ is the repopulation rate, with repopulation beginning T k days after the start of treatment. The TCP is found by assuming Poisson statistics and calculating the probability of there being no viable tumor cells remaining. Considering a tumor divided into N equalsized voxels each of volume v, the probability of killing all tumor cells within a single voxel i is given by
͑2͒
where i is the clonogenic cell density in voxel i and D i the dose delivered to voxel i. Note that the radiosensitivity parameters are also allowed to vary spatially to account for local variations in oxygenation. 17, 18 The overall TCP for the whole tumor is then the product of the TCPs for all voxels:
͑3͒
The local values of the linear and quadratic terms of radiosensitivity are given by intrinsic radiosensitivity terms ␣ and ␤ multiplied by factors A i and B i , respectively, such that
where A i and B i are functions of the local oxygenation. The oxygen dependence takes the form proposed by Wouters and Brown:
where p i is the partial pressure of oxygen in voxel i, OER ␣ max and OER ␤ max are the maximum oxygen enhancement ratios for ␣ and ␤, respectively, and K m is the oxygen partial pressure at which half-maximum sensitization occurs.
For simplicity, we assume an idealized situation where we can precisely deliver any desired dose distribution, with the resolution of the biological imaging voxels. For the purposes of this analysis, we can then simply consider a tumor as a series of N voxels with differing biological properties and dose prescriptions. We also assume knowledge of the intrinsic radiosensitivity parameters ␣ and ␤ for the individual tumor, 15 enabling us to use single values of ␣ and ␤ rather than a population distribution. However, we subsequently consider the impact of variations in these parameters.
II.B. Dose optimization
In order to allow a fair quantitative comparison between plans of differing complexity, we used a method which maximizes the TCP by redistributing dose between compartments, subject to a fixed integral dose. 8, 16, 20 This method has been previously described by the authors. 
II.C. Tumor models
The key biological parameters affecting the TCP in a given voxel are the clonogen density, the oxygenation, and the proliferation rate. We have investigated the behavior of simple model tumors in which either clonogen density, oxygenation, or proliferation is allowed to vary across the tumor, with that variation taking the form of four different simple mathematical functions. We also present data for models in which variations in oxygenation are based on published oxygen partial pressure histograms for a number of tumor types. Finally, we constructed tumor models from a number of clinical 18 F-fluorodeoxyglucose ͑FDG͒ PET data sets. While it would be inappropriate to use FDG uptake as a surrogate for clonogen density, hypoxia, or proliferation, it is believed to be influenced by all these factors. [21] [22] [23] [24] [25] [26] We have therefore used FDG-PET data from three lung tumors, not to demonstrate a clinical application but merely to indicate typical patterns of biological heterogeneity. For each scan we created models taking the PET data to represent variations in clonogen density, oxygenation, or a combination in order to investigate whether the predictions for these models fell within the range of the mathematical models presented.
We have chosen radiobiological parameters from the literature to represent a typical lung tumor: ␣ = 0. 
II.C.1. Simple models
The simple mathematical models each contain 1000 voxels, across which clonogen density, oxygenation, or proliferation varies as a linear, exponential, sigmoidal, or logarithmic function of voxel number. For models with heterogeneous clonogen density the oxygen pressure has been set to a uniform 100 mm Hg. To aid comparison the tumors have been normalized so that they all have a minimum density of 10 5 clonogens per voxel ͑which is approximately the lower detection limit using current PET techniques 21 ͒, and all contain a total of 10 9 clonogens. 28 This means that a uniform dose gives the same total TCP for each model.
For models with heterogeneous oxygenation, the partial pressure of oxygen is allowed to vary linearly, exponentially, sigmoidally, and logarithmically between 1 and 100 mm Hg. Additional models are derived by linearly interpolating published oxygen partial pressure histograms for squamous cell carcinomas, breast cancers, and gastric adenocarcinoma. 29 For these hypoxic models, the total number of clonogens has been chosen such that ͑i͒ a uniform irradiation to 64 Gy results in the same TCP for each model, ͑ii͒ the maximum achievable TCP is significantly greater than 0, and ͑iii͒ clonogen densities fall within a clinically realistic range for all models. When the uniform dose TCP is 0.001, the total clonogen number ranges from 1.03ϫ 10 5 for the sigmoidal model to 1.95ϫ 10 6 for the logarithmic model, and the maximum achievable TCP is greater than 0.9 in each case.
For models with a heterogeneous proliferation rate, ␥ has been allowed to vary by a factor of 100 from a maximum value of 0.231 day −1 , with variations taking linear, exponential, sigmoidal, and logarithmic forms. The partial pressure of oxygen is set to a uniform 100 mm Hg and again the total number of clonogens is normalized such that uniform irradiation results in the same TCP for each model. Figure 2 shows the variation in clonogen density, oxygenation, or proliferation rate for each of these models.
II.C.2. PET-based models
The PET-based models were created by extracting a cuboid of data from a clinical 18 F-FDG PET scan, centered on a lung tumor. Background voxels were removed using a threshold of 15% of the peak voxel value and the remaining FIG. 2. ͑a͒ Clonogen distributions for the simple mathematical models ͑lin-ear, exponential, sigmoid, and logarithmic͒. ͑b͒ Oxygen distributions for the simple mathematical models. ͑c͒ Oxygen distribution for the models based on published oxygen partial pressure histograms: Squamous cell carcinoma ͑SCC͒, breast cancer ͑BC͒, and gastric adenocarcinoma ͑GAC͒. ͑d͒ Proliferation rates for the simple mathematical models. voxels sorted into order of intensity. For all models, this threshold was within Ϯ0.5 of the absolute SUV threshold of 2.5 proposed by Paulino and Johnstone for the segmentation of tumors 30 and we determined that our results were insensitive to variations in this threshold ͑data not presented͒. We consider models in which variations in voxel intensity are taken to reflect variations in either clonogen number or hypoxia or both.
For models with heterogeneous clonogen density, image intensities were converted into clonogen numbers assuming a linear relationship between FDG uptake and clonogen density 21, 22 and normalizing to give a minimum clonogen density of 10 5 per voxel and a total clonogen number of 10 9 as before. The total number of tumor voxels varies between 237 and 2864 for these models. For models with heterogeneous oxygenation we have assumed that FDG uptake is negatively correlated with oxygenation. [23] [24] [25] Oxygen partial pressures have been allowed to vary within a range of 1-100 mm Hg and we have again chosen a clonogen density for each model which results in a TCP of 0.001 for a uniform irradiation to 64 Gy. This combination of parameters again allows a significant TCP to be achieved by redistributing dose while keeping all parameters within a clinically realistic range. Finally, for models in which both clonogen density and oxygenation are allowed to vary, the clonogen distribution from the first PET model is combined with the oxygen distribution from the second for each tumor. It should be noted that these models imply that hypoxia is inversely related to clonogen density, which is unlikely to be clinically realistic as it suggests that hypoxic cells are more viable than normoxic cells. However, they are included in order to present a worst-case scenario in which variations in clonogen density and oxygenation interact constructively, as this is the situation in which the greatest dose heterogeneity will be required. Figure 3 shows PET images taken through the center of each tumor and the derived clonogen and oxygen distributions for each of the PET models.
II.D. Setting compartment boundaries
II.D.1. Heterogeneous clonogen density
In general a nonuniform dose distribution is designed by allocating tumor voxels to a number of compartments, then optimizing the prescribed doses to those compartments. For models in which only clonogen density varies between voxels, the optimal dose distribution can be directly calculated for any number of compartments, as described above. 15 We investigated a number of methods for allocating voxels to different compartments. These methods fall into three categories: Simple rules based on the clonogen density distribution, numerical optimizations in which the boundary positions are iteratively adjusted to maximize the total TCP, and methods in which the optimal dose distribution is calculated with an individualized dose to every voxel, and compartments are designed based on this ideal dose distribution.
II.D.1.a. Simple methods.
• Equal volumes ͑Vol͒: The boundaries are set such that each compartment contains the same number of voxels.
• Equal clonogens ͑Clons͒: The boundaries are set such that each compartment contains the same total number of clonogens.
• Evenly spaced clonogen density thresholds ͑Thresh͒:
Compartments have evenly spaced boundaries between the predetermined maximum and minimum clonogen density limits.
II.D.1.b. Iterative methods.
• Exhaustive search ͑Exh͒: The dose distribution is optimized to give the maximum achievable TCP for every possible combination of boundary positions, and the set of positions resulting in the highest TCP is chosen.
• Gradient ascent ͑Grad͒: Boundary positions are iteratively optimized using a gradient ascent method to find the maximum overall TCP.
II.D.1.c. Ideal dose distribution methods.
• Evenly spaced dose levels ͑Dose͒: Initial compartment doses are set by averaging over the ideal dose distribution within each compartment, with boundaries chosen to give approximately evenly spaced dose levels.
• Optimum mean square quantizer ͑OMQ͒: This method calculates the compartment boundaries and dose levels which result in a dose profile which is the best fit to the ideal dose distribution. This is analogous to the problem of designing multiple static fields to give the best fit to an optimal fluence profile. 31, 32 Details are given in the Appendix. In each case, once the boundaries have been set using one of these methods, the dose levels are reoptimized to ensure that the maximum possible TCP is achieved for each configuration.
II.D.2. Heterogeneous oxygenation or proliferation rate
For tumors with heterogeneous oxygenation ͑with or without clonogen density variations͒, for small numbers of compartments the dose distribution was optimized by iteratively adjusting the boundary positions to maximize TCP. For each set of boundary positions, compartment dose is given by the average voxel dose delivered to a compartment by the ideal dose distribution. Where the number of compartments was 7 or greater, it was found that setting compartment boundaries using the even dose level approach gave TCPs within 0.5% of this iterative method in all cases. This method was therefore adopted for larger numbers of compartments as it reduced calculation times and eliminated the risk of being influenced by local minima. A similar approach was taken to optimizing dose distributions for models with heterogeneous proliferation rates.
II.D.3. Sensitivity to variations in chosen parameter values
The calculated TCP values for all these models will be sensitive to variations in the precise value of each of the fixed parameters chosen for that model. In order to determine whether conclusions drawn from the behavior of these models are robust against such variations, we also repeated our analysis for a subset of the models with previously fixed values allowed to vary. We would expect our results to be particularly sensitive to our choice of oxygen pressures. We present results for the following: The sigmoidal clonogen density model, with the uniform oxygenation allowed to vary; the sigmoidal oxygenation model, with the minimum partial pressure of oxygen allowed to vary; and the model based on the gastric adenocarcinoma oxygen histogram, with the radiosensitivity allowed to vary. Figure 4͑a͒ shows an exhaustive search of boundary positions for the two-compartment case for each of the simple mathematical tumor models, with the dose levels optimized to give the maximum achievable TCP for each boundary position. This illustrates the importance of dividing the tumor in such a way as to enable the maximum possible benefit from a nonuniform dose distribution. It also shows that the potential benefits of redistributing dose depend on the heterogeneity of the tumor-the improvements in TCP are much greater for tumors with exponential and sigmoidal variations in clonogen density than for the largely homogeneous logarithmic model. Of course in the extreme case of a uniform tumor, no improvement in TCP would be possible, since a uniform distribution is optimal in this case. 33 Figures 4͑b͒ and 4͑c͒ show the relationship between complexity and TCP for the equal volumes, equal clonogens, even clonogen density thresholds, and even dose levels methods for the exponential and sigmoidal tumor models. It is clear that the relative performance of the simple methods depends on the form of tumor heterogeneity. The even dose level approach works consistently well compared with the other simple methods when there is significant inhomogeneity across the tumor. Figure 4͑d͒ shows again the even dose level approach along with the iterative methods ͑exhaustive search and gradient ascent͒ and the OMQ for the same four tumor models. Again we see that the potential benefits of dose redistribution depend on the heterogeneity of the tumor, but also that for all these models, most of the benefit occurs within the first few compartments. In all cases greater than 99.5% of the maximum achievable TCP is reached within four compartments. The exhaustive search was only carried out for up to three compartments since beyond this it becomes extremely computationally intensive. All these methods generally achieve similar results, suggesting that the gradient ascent method is not significantly hampered by local maxima for these models, although this may not be true for all cases ͑indeed this method gives slightly suboptimal results for the sigmoidal model in the four-to seven-compartment range͒. The OMQ approach has the advantage that it is an analytical method, it is relatively fast, and it appears stable provided the number of compartments is small compared to the number of voxels.
III. RESULTS
III.A. Simple models
III.A.1. Heterogeneous clonogen density
III.A.2. Heterogeneous oxygenation or proliferation rate
Figures 5͑a͒ and 5͑b͒ show the relationship between TCP and number of dose levels for the mathematically derived and clinically derived hypoxic models, respectively. Figure  5͑c͒ shows results for the mathematical models with varying proliferation rate. Once again the majority of the benefit occurs within the first few compartments for all these models. Figure 6 shows the complexity versus TCP curve for a number of the models previously presented, with a key fixed parameter allowed to vary in each case. In Fig. 6͑a͒ , the analysis for the sigmoidal clonogen density model is repeated with the uniform partial pressure of oxygen varying between 20 and 100 mm Hg. Figure 6͑b͒ shows results for the sigmoidal oxygenation model, with the minimum partial pressure of oxygen varying between 0 and 10 mm Hg. The total clonogen number was fixed equal to that used for the original model. Figure 6͑c͒ shows the effect of varying the radiosensitivity parameters on the behavior of the hypoxic model based on the gastric adenocarcinoma oxygen histogram. In this case ␣ was varied between 0.15 and 0.5 Gy −1 with the ␣ / ␤ ratio fixed at 10 and the uniform clonogen density scaled to give the same TCP in each case for a uniform dose of 64 Gy. In each case investigated, while a change in parameter values affected the absolute TCP values and the initial slope of the curve, the overall shape of the curve was largely unaffected.
III.A.3. Sensitivity to variations in chosen parameter values
FIG. 4. ͑a͒
The maximum achievable TCP as a function of boundary position for the two-compartment case for each of the simple models with heterogeneous clonogen density ͑linear, exponential, sigmoid, and logarithmic͒. ͑b͒ TCP as a function of complexity for the model with exponentially varying clonogen density using the equal volume, equal clonogens, evenly spaced clonogen density threshold, and evenly spaced dose level methods. ͑c͒ TCP as a function of complexity for the model with sigmoidally varying clonogen density using the equal volume, equal clonogens, evenly spaced clonogen density threshold, and evenly spaced dose level methods. ͑d͒ TCP as a function of complexity for the even dose levels ͑Dose͒, gradient ascent ͑Grad͒, optimum mean square quantizer ͑OMQ͒, and exhaustive search ͑Exh͒ methods for the simple models with heterogeneous clonogen density ͑linear, exponential, sigmoid, and logarithmic͒.
III.B. PET-based models
Comparing the distributions of uptake in Fig. 3 with the simple models in Fig. 2 , we would expect the results for the PET model tumors to fall within the range of the results for the mathematical models investigated. Figure 7 shows results of the gradient ascent method for each of the PET models. The resulting dose prescription maps are also shown for one to five compartments and for the optimal dose distribution in each case. Note that these maps represent a single slice through each tumor, and that although the most heterogeneous slice of each model has been chosen, in some cases not all the available dose levels are present on the slice displayed. It is clear that where both clonogen density and oxygenation vary across the tumor, hypoxia is the dominant effect in determining the most effective dose distribution. Again, the majority of the benefit is attained within the first few compartments for all the models investigated.
IV. DISCUSSION
The results presented above suggest that, for a wide range of heterogeneous biological distributions, the vast majority of the benefit of dose redistribution can be attained using very few dose levels. However, this is only true if both the prescribed dose levels and the dividing lines between compartments are well chosen. Due to the uncertainties inherent in interpreting biological image data, previous work demonstrating the feasibility of dose painting has tended to link the biological image intensities and subsequent dose prescription levels somewhat arbitrarily, often quantizing either biological parameters or dose into very few levels. [5] [6] [7] [8] [9] 16 For example, Yang and Xing 8 presented an elegant method for optimizing a nonuniform dose prescription on the voxel scale but demonstrated it using models in which the biological variations are quantized into a few discrete levels. Das et al. 7 considered continuously varying biological distributions and dose prescriptions but generated their prescription by setting dose proportional to PET voxel intensity. Sovik et al. 11 used FIG. 5 . ͑a͒ TCP as a function of complexity for the simple mathematical models with heterogeneous oxygenation ͑linear, exponential, sigmoid, and logarithmic͒. ͑b͒ TCP as a function of complexity for the simple models based on published oxygen partial pressure histograms: Squamous cell carcinoma ͑SCC͒, breast cancer ͑BC͒, and gastric adenocarcinoma ͑GAC͒. ͑c͒ TCP as a function of complexity for the simple mathematical models with heterogeneous proliferation rate ͑linear, exponential, sigmoid, and logarithmic͒. very similar radiobiological models to those presented here to investigate the impact of varying the number of dose levels on the benefit of redistributing dose for four hypoxic tumor models. We have expanded upon this work to investigate a wide range of theoretically and clinically derived biological distributions to determine whether their conclusions are generally applicable. Taking into account variations in clonogen density, oxygenation, and proliferation rate, our results are consistent with their observation that increasing the number of dose levels beyond 4 yields little additional benefit. We have, however, demonstrated a number of methods to approximate the optimal dose prescription for any number of discrete dose levels for a given nonuniform tumor. We have made the simplifying assumption that any desired dose distribution can be accurately delivered. While this is clearly not a realistic expectation, beam-shaping devices with a resolution comparable to that of most functional images are now widely available. For example, multileaf collimators with an effective leaf width of 3-5 mm are not uncommon, giving the capability to produce fluence modulations at the same scale as a typical PET voxel. While the steepest achievable dose gradients will be fundamentally limited by the penumbra of the beam-shaping device and small-field dosimetry remains problematic, we would nevertheless expect to be able to deliver a close approximation to the desired dose distribution in the majority of cases. 34 The major limiting factors for dose painting therefore remain the quantification of biological parameters from functional imaging and the validation of models predicting tissue response. 35 It should be noted that our observations relate to a prescribed target dose distribution, not to a final planned clinical dose. In the absence of normal tissue dose constraints, we FIG. 7 . TCP as a function of complexity for each of the PET-based models. The resulting dose prescription maps are also shown for one to five compartments and for the optimal dose distribution for the cases in which PET uptake represents ͑a͒ clonogen density, ͑b͒ hypoxia, and ͑c͒ both.
would expect these two distributions to be closely matched, as discussed above. However, where organs at risk are present close to or overlapping with the target, a reduction in the target dose may be necessary in these regions. This could of course lead to an increase in the number of dose levels present in the final planned target dose distribution.
The resolution of the dose prescription is limited by the PET resolution and/or the resolution with which we can physically modulate dose, whichever is coarser. Biological heterogeneities are likely to exist on a much finer scale than we can hope to either image noninvasively or modulate external-beam dose. Acquiring biological information on a finer scale than the dose prescription voxel size would result in the dose to each prescription voxel being largely determined by the least radiosensitive region within that voxel. This means that our current approach, in which we take each PET voxel value to be representative of all cells within that PET voxel, is likely to underestimate both the heterogeneity of the optimal dose distribution and the potential benefit of dose redistribution. 36 However, we have demonstrated that a wide range of optimal dose distributions, optimized making a variety of assumptions, can be well approximated using very few dose levels and a small increase in the dose range of the optimal dose distribution is unlikely to affect this conclusion.
It is clear that where significant hypoxia exists, this will dominate the dose prescription, and the increase in TCP achieved by dose redistribution is modest for the models in which only clonogen density or proliferation varies. However, even an increase of 5% in TCP could be considered clinically important, particularly if it can be achieved with only a modest increase in the complexity of the plan. In the case of common cancers such as lung or prostate, even a small improvement in TCP could result in an improved outcome for a large number of patients.
The initial steepness of the TCP versus complexity curve for all significantly inhomogeneous tumors indicates that a relatively simple dose prescription consisting of two to five dose levels will be sufficient to produce a dose distribution that is very close to optimal. This will simplify the task of designing treatment planning systems capable of fully utilizing biological information from functional imaging to optimize planned dose distributions. Plotting this curve for individual tumors, taking into account variations in clonogen density, oxygenation, and proliferation, could assist in choosing the number of dose levels to use in each specific case. This would also enable the identification of cases for which the overall benefit of dose redistribution is minimal and a simple uniform irradiation would be the most appropriate treatment. We have demonstrated a number of methods for assigning dose levels which could easily be implemented within a treatment planning system. The even dose levels method, the OMQ, and the iterative approaches all appear to give comparable results, so the most appropriate method will depend on the relative importance of robustness and computational efficiency. The optimal approach is likely to be one in which, for small numbers of dose levels, the boundaries are iteratively optimized, while the even dose level approach is used where larger numbers of dose levels are required and iterative optimization becomes computationally prohibitive.
V. CONCLUSIONS
When designing nonuniform dose prescriptions for biologically heterogeneous tumors, only a few dose levels are required provided these dose levels are well chosen. The quantification of biological parameters from functional imaging remains the limiting factor in the clinical implementation of dose painting.
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APPENDIX: OPTIMUM MEAN SQUARE QUANTIZER METHOD
A quantizer maps a continuous variable x onto a discrete variable xЈ, which takes values from a finite set of numbers. For a quantizer with L levels, this mapping is achieved by defining a set of "transition levels" ͕t 1 , ... ,t L+1 ͖ and assigning "reconstruction levels" ͕r 1 , ... . ,r L ͖ such that if t k Ͻ x Ͻ t k+1 , then xЈ = r k . The optimum mean square quantizer sets both transition and reconstruction levels so as to minimize the mean square error from the original distribution for a given number of quantization levels. 31 Let x be the prescribed voxel dose, with a continuous probability density function p x ͑x͒ determined from the ideal dose distribution. The mean square error is then
͑x − r i ͒ 2 p x ͑x͒dx.
͑A1͒
The error can be minimized by differentiating with respect to both t k and r k and setting the results to zero:
͑x − r k ͒p x ͑x͒dx = 0, ͑A3͒ If we set t 1 and t L+1 equal to the minimum and maximum voxel doses from the ideal distribution, Eqs. ͑A4͒ and ͑A5͒ can be solved using an iterative method to give both transition levels and prescribed dose levels.
